No insider purchase over the last 90 days. The latest, by 이광식, was filed 30 Oct 2025.
Who traded when
BuySaleSince the insiders bought
- -10.0%Entry ₩11,510 · Close 21 Oct 2026 ₩10,360
- -10.0%Entry ₩11,510 · Close 21 Oct 2026 ₩10,360
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
- 0KRXDART:20260511000215
- 135,224 sharesKRXDART:20251030000519Canonical exit: 28 Jan 2026 (T+90)
- 1,860,000 sharesShareKRXDART:20251030000460Canonical exit: 28 Jan 2026 (T+90)
- 1,860,000 sharesShareKRXDART:20251030000422
- 205,961 sharesKRXDART:20251001000392
- ●Executives0DART
- ●Executives0DART
- ShareKRXDART:20231222000463
- ShareKRXDART:20231213000400
- ShareKRXDART:20231027000219
- 0KRXDART:20230908000530
- 0KRXDART:20230810000490
- ShareKRXDART:20230808000102
- 0KRXDART:20230726000204
- ShareKRXDART:20230726000200
- 0KRXDART:20230608000120
- 0KRXDART:20220705000186
- 0KRXDART:20210827000693
- 0KRXDART:20210702000328
- 0KRXDART:20210405002639
20 of 20 declarations
About Whan In Pharm Co.,Ltd.
The record of 환인제약 (Whan In Pharm Co.,Ltd.), a South Korean health care company valued at KRW 192.2 billion with 23.3% held by insiders, is light on trades: 2 purchases and 2 sales out of 20 filings, with no amount stated. The other 16 filings are neither purchases nor sales.
Two filers weigh most: 이원범 (대표이사 사장), with 8 filings including 1 purchase, and the asset manager 피델리티매니지먼트앤리서치컴퍼니엘엘씨, with 8 filings and no trade. 이광식, filed as 대량보유자, has 3 filings, one purchase and one sale. 국민연금공단 signs the other sale. On October 30, 2025, 2 distinct filers bought.
Read moreShow less
These 20 filings from 4 filers were published between April 5, 2021 and May 11, 2026: 3 in 2021, 1 in 2022, 9 in 2023, 6 in 2025 and 1 in 2026. Over the last twelve months there are 4 filings, of which 2 purchases and 1 sale. Publication takes a median of 7 days.
